- Report
- August 2024
- 66 Pages
Global
From €569EUR$625USD£494GBP
€1138EUR$1,250USD£988GBP
- Report
- March 2025
- 250 Pages
Global
From €4089EUR$4,490USD£3,547GBP
- Report
- July 2024
- 317 Pages
Global
From €4325EUR$4,750USD£3,753GBP
- Report
- November 2024
- 183 Pages
Global
From €4098EUR$4,500USD£3,555GBP
- Report
- September 2024
- 140 Pages
Asia Pacific
From €4325EUR$4,750USD£3,753GBP
- Report
- January 2025
- 255 Pages
Global
From €4508EUR$4,950USD£3,911GBP
- Report
- December 2024
- 274 Pages
Global
From €4508EUR$4,950USD£3,911GBP
- Report
- November 2024
- 130 Pages
Global
From €4234EUR$4,650USD£3,674GBP
- Report
- October 2024
- 187 Pages
Global
From €3228EUR$3,545USD£2,801GBP
€3587EUR$3,939USD£3,112GBP
- Report
- January 2025
- 145 Pages
Global
From €5418EUR$5,950USD£4,701GBP
- Report
- June 2024
- 144 Pages
Global
From €5418EUR$5,950USD£4,701GBP
- Report
- May 2024
- 172 Pages
Global
From €5418EUR$5,950USD£4,701GBP
- Report
- June 2024
Global
From €4508EUR$4,950USD£3,911GBP
- Report
- April 2025
- 200 Pages
Global
From €4089EUR$4,490USD£3,547GBP
- Report
- April 2025
- 200 Pages
Global
From €4089EUR$4,490USD£3,547GBP
- Report
- April 2025
- 200 Pages
Global
From €4089EUR$4,490USD£3,547GBP
- Report
- November 2024
- 150 Pages
Global
From €4417EUR$4,850USD£3,832GBP
- Report
- October 2024
- 200 Pages
Global
From €3415EUR$3,750USD£2,963GBP
- Report
- December 2024
- 196 Pages
Global
From €2277EUR$2,500USD£1,975GBP
- Report
- May 2024
- 169 Pages
Global
From €2277EUR$2,500USD£1,975GBP

The Contract Development and Manufacturing Organization (CDMO) market is a subset of the pharmaceutical manufacturing industry. It is composed of companies that provide services to pharmaceutical and biotechnology companies, such as drug development, clinical trial materials, and commercial manufacturing. CDMOs are typically engaged by pharmaceutical companies to outsource the development and manufacturing of their products. This allows the pharmaceutical companies to focus on their core competencies, such as drug discovery and marketing.
CDMOs provide a range of services, including process development, analytical services, formulation development, clinical trial materials, and commercial manufacturing. They also provide regulatory support, such as filing of Investigational New Drug (IND) applications and New Drug Applications (NDAs).
Some of the major players in the CDMO market include Lonza, Patheon, Boehringer Ingelheim, Catalent, and Ajinomoto. Other companies in the market include Recipharm, Jubilant, Vetter, and Fareva. Show Less Read more